Affymetrix's Q3 Revenues Rise 24 Percent | GenomeWeb

NEW YORK (GenomeWeb News) – Affymetrix's third-quarter revenues jumped 24 percent year over year with the addition of eBioscience, the microarray firm announced after the close of the market on Monday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.